Key result
The ATOPE+ mHealth system demonstrated good to excellent reliability for assessing autonomic balance (ICC 0.87), recovery (ICC 0.93), and emotional distress (ICC 0.94) in breast cancer survivors.
Why the study?
Physical exercise benefits breast cancer survivors, but avoiding nonfunctional overreaching is crucial due to physiological dysregulation that may increase morbidities and mortality.
Does the ATOPE+ mHealth system reliably and validly assess autonomic balance and wellness parameters compared to criterion instruments in breast cancer survivors?
Cross-Sectional (n=21)
No
Does the ATOPE+ mHealth system reliably and validly assess autonomic balance and wellness parameters compared to criterion instruments in breast cancer survivors?
The ATOPE+ mHealth system is a reliable and valid tool for remotely assessing autonomic balance, recovery, sleep, and emotional distress in breast cancer survivors, which can support individualized exercise prescription.
Answers are grounded in this paper and cite their sources.
ATOPE+ reliably estimates autonomic balance in BCS; leaves open utility for preventing overreaching in prospective trials.
Physical exercise is known to be beneficial for breast cancer survivors (BCS). However, avoiding nonfunctional overreaching is crucial in this population, as they are in physiological dysregulation. These factors could decrease their exercise capacity or facilitate nonfunctional overreaching, which can increase their risk of additional morbidities and even all-cause mortality. The focus of this study is to evaluate the reliability and validity of the ATOPE+ mHealth system to estimate autonomic balance and specific wellness parameters associated with BCS' perceived load, thereby informing nonlinear prescriptions in individualized physical exercise programs for BCS.Twenty-two BCS were included in the reliability and validity analysis. Measures were taken for four days, including morning autonomic balance by heart rate variability, self-reported perception of recovery from exercise, sleep satisfaction, emotional distress and fatigue after exertion. Measures were taken utilizing the ATOPE+ mHealth system application. The results of these measures were compared with criterion instruments to assess validity.The reliability results indicated that the intraclass correlation coefficient (ICC) showed an excellent correlation for recovery (0.93; 95% CI 0.85-0.96) and distress (0.94, 95% CI 0.89-0.97) as well as good correlation for the natural logarithm of the mean square root differences of the standard deviation (LnRMSSD) (0.87; 95% CI 0.74-0.94). Sleep satisfaction also showed an excellent correlation with a weighted kappa of 0.83. The validity results showed no significant differences, except for fatigue. ATOPE+ is reliable and valid for remotely assessing autonomic balance, perception of recovery, sleep satisfaction and emotional distress in BCS; however, it is not for fatigue. This highlights that ATOPE+ could be an easy and efficient system used to assess readiness in BCS, and could help to improve their health by supporting the prescription of optimal and safe physical exercise. Trial registration NCT03787966 ClinicalTrials.gov, December 2019 [ATOPE project]. https://clinicaltrials.gov/ct2/show/NCT03787966 .
No takes yet. Share an insight, caveat, or question.
Postigo-Martín et al. (2022) conducted a cross-sectional in Breast cancer (n=21). ATOPE+ mHealth system vs. Criterion instruments (Holter monitor and validated scales) was evaluated on Reliability of ATOPE+ for assessing autonomic balance (LnRMSSD) (ICC 0.87, 95% CI 0.74-0.94). The ATOPE+ mHealth system demonstrated good to excellent reliability for assessing autonomic balance (ICC 0.87), recovery (ICC 0.93), and emotional distress (ICC 0.94) in breast cancer survivors.
Synapse has enriched 10 related papers. Consider them for comparative context: